Lumeris Chief Financial Officer, James Starr, discusses the role ACOs play in the evolution of care models and new financial models.
Lumeris Medical Director, Dr. Jim Riopelle M.D. discusses the importance of physician adoption of population health management in a risk environment.
Lumeris’ Vice President of Technical Solutions Keith Blankenship discusses the elements beyond big data that are critical for accountable care success.
Lumeris helped with the St. Louis region’s strongest investment capital period over the past decade. In the previous two quarters, venture capital investment in the St. Louis region was $5.5 million (first quarter) and $19.6 million (second quarter). The significant increase to $78.5 million in the third quarter was a result of the equity financing received by Lumeris, $71 million.
Lumeris will use the $71 million in financing to expand into 20 markets before the end of 2014. W. Michael Long, Chairman and Chief Executive Officer of Essence Group Holdings Corporation and Lumeris said expansion will help the company contract with more health care organizations.
Lumeris’ parent company announces $71 million in new financing.
Coverage of Lumeris funding news and expansion from eight to 20 U.S. markets by the end of 2015.
Lumeris capital raise of $71 million is cited in The Wall Street Journal’s blog (Venture Capital Dispatch) about investment interest in the industry.
Essence Group raises $71 million to enhance position in population health management market.
Lumeris’ population health management solutions are featured, as well as the resulting $71 million in private-equity funding that will support expanding those solutions into 12 additional markets.